Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 1
2018 2
2019 2
2020 1
2021 3
2022 2
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders.
Zhang G, Jurinovic V, Bartels S, Christgen M, Christgen H, Kandt LD, Mishieva L, Ni H, Raap M, Klein J, Katzke AL, Hofmann W, Steinemann D, Kates RE, Gluz O, Graeser M, Kümmel S, Nitz U, Plass C, Lehmann U, Zu Eulenburg C, Mansmann U, Gerhäuser C, Harbeck N, Kreipe HH. Zhang G, et al. Among authors: raap m. J Clin Invest. 2025 Jul 24;135(19):e177813. doi: 10.1172/JCI177813. eCollection 2025 Oct 1. J Clin Invest. 2025. PMID: 40705465 Free PMC article. Clinical Trial.
Substance P activates human eosinophils.
Raap M, Rüdrich U, Ständer S, Gehring M, Kapp A, Raap U. Raap M, et al. Exp Dermatol. 2015 Jul;24(7):557-9. doi: 10.1111/exd.12717. Epub 2015 May 8. Exp Dermatol. 2015. PMID: 25865137 No abstract available.
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
Christgen M, Kandt LD, Antonopoulos W, Bartels S, Van Bockstal MR, Bredt M, Brito MJ, Christgen H, Colpaert C, Cserni B, Cserni G, Daemmrich ME, Danebrock R, Dedeurwaerdere F, van Deurzen CH, Erber R, Fathke C, Feist H, Fiche M, Gonzalez CA, Ter Hoeve ND, Kooreman L, Krech T, Kristiansen G, Kulka J, Laenger F, Lafos M, Lehmann U, Martin-Martinez MD, Mueller S, Pelz E, Raap M, Ravarino A, Reineke-Plaass T, Schaumann N, Schelfhout AM, De Schepper M, Schlue J, Van de Vijver K, Waelput W, Wellmann A, Graeser M, Gluz O, Kuemmel S, Nitz U, Harbeck N, Desmedt C, Floris G, Derksen PW, van Diest PJ, Vincent-Salomon A, Kreipe H. Christgen M, et al. Among authors: raap m. J Pathol Clin Res. 2022 Mar;8(2):191-205. doi: 10.1002/cjp2.253. Epub 2021 Dec 10. J Pathol Clin Res. 2022. PMID: 34889530 Free PMC article.
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial.
Radner M, Burmeister S, Jóźwiak K, Schaumann N, Gronewold M, Raap M, Bartels S, Christgen H, Kandt LD, Hillmann P, Lehmann U, Gluz O, Graeser M, Kümmel S, Eulenburg CZ, Harbeck N, Kreipe H, Christgen M. Radner M, et al. Among authors: raap m. Lab Invest. 2025 Jun;105(6):104125. doi: 10.1016/j.labinv.2025.104125. Epub 2025 Mar 4. Lab Invest. 2025. PMID: 40049332 Free article. Clinical Trial.
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
Christgen M, Gluz O, Harbeck N, Kates RE, Raap M, Christgen H, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Krabisch P, Just M, Augustin D, Graeser M, Baehner F, Wuerstlein R, Nitz U, Kreipe H; West German Study Group PlanB Investigators. Christgen M, et al. Among authors: raap m. Cancer. 2020 Nov 15;126(22):4847-4858. doi: 10.1002/cncr.33104. Epub 2020 Aug 11. Cancer. 2020. PMID: 32780421 Free article.
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
Grote I, Bartels S, Christgen H, Radner M, Gronewold M, Kandt L, Raap M, Lehmann U, Gluz O, Graeser M, Kuemmel S, Nitz U, Harbeck N, Kreipe H, Christgen M. Grote I, et al. Among authors: raap m. Mod Pathol. 2022 Dec;35(12):1804-1811. doi: 10.1038/s41379-022-01130-7. Epub 2022 Jul 16. Mod Pathol. 2022. PMID: 35842479 Free PMC article.
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
Grote I, Bartels S, Kandt L, Bollmann L, Christgen H, Gronewold M, Raap M, Lehmann U, Gluz O, Nitz U, Kuemmel S, Zu Eulenburg C, Braun M, Aktas B, Grischke EM, Schumacher C, Luedtke-Heckenkamp K, Kates R, Wuerstlein R, Graeser M, Harbeck N, Christgen M, Kreipe H. Grote I, et al. Among authors: raap m. Cancer Med. 2021 Dec;10(23):8581-8594. doi: 10.1002/cam4.4376. Epub 2021 Nov 14. Cancer Med. 2021. PMID: 34779146 Free PMC article.
15 results